May 5, 2015:
On February 3, 2015, the Food and Drug Administration approved a new drug called Ibrance for postmenopausal women with advanced breast cancer.
FDA approves Ibrance for postmenopausal women with advanced breast cancer | FDA
More:
May 5, 2015:
On February 3, 2015, the Food and Drug Administration approved a new drug called Ibrance for postmenopausal women with advanced breast cancer.
FDA approves Ibrance for postmenopausal women with advanced breast cancer | FDA
More: